{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:05:57Z","timestamp":1786993557690,"version":"build-2736575974"},"reference-count":41,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"vor","delay-in-days":1461,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["kidney-international.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.kint.2021.01.016","type":"journal-article","created":{"date-parts":[[2021,2,23]],"date-time":"2021-02-23T00:30:13Z","timestamp":1614040213000},"page":"1342-1353","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Hyperphosphatemia in chronic kidney disease exacerbates atherosclerosis via a mannosidases-mediated complex-type conversion of SCAP N-glycans"],"prefix":"10.1016","volume":"99","author":[{"given":"Chao","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quan","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Gan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John F.","family":"Moorhead","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zac","family":"Varghese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Ouyang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5199-4971","authenticated-orcid":false,"given":"Xiong Z.","family":"Ruan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.kint.2021.01.016_bib1","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0140-6736(20)30045-3","article-title":"Global, regional, and national burden of chronic kidney disease, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"395","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.kint.2021.01.016_bib2","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1053\/j.ajkd.2015.06.028","article-title":"Cholesterol metabolism in CKD","volume":"66","author":"Reiss","year":"2015","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2021.01.016_bib3","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1056\/NEJMoa043545","article-title":"Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis","volume":"353","author":"Wanner","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.kint.2021.01.016_bib4","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1056\/NEJMoa0810177","article-title":"Rosuvastatin and cardiovascular events in patients undergoing hemodialysis","volume":"360","author":"Fellstr\u00f6m","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.kint.2021.01.016_bib5","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1016\/S0140-6736(11)60739-3","article-title":"The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial","volume":"377","author":"Baigent","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.kint.2021.01.016_bib6","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1152\/physrev.00022.2017","article-title":"Phosphate as a signaling molecule and its sensing mechanism","volume":"98","author":"Michigami","year":"2018","journal-title":"Physiol Rev"},{"key":"10.1016\/j.kint.2021.01.016_bib7","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/nrneph.2016.164","article-title":"The role of phosphate in kidney disease","volume":"13","author":"Vervloet","year":"2017","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.kint.2021.01.016_bib8","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.bone.2016.11.012","article-title":"Vascular calcification in CKD-MBD: roles for phosphate, FGF23, and Klotho","volume":"100","author":"Yamada","year":"2017","journal-title":"Bone"},{"key":"10.1016\/j.kint.2021.01.016_bib9","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.kint.2017.11.036","article-title":"Prevention and treatment of hyperphosphatemia in chronic kidney disease","volume":"93","author":"Vervloet","year":"2018","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2021.01.016_bib10","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1681\/ASN.2008020141","article-title":"Serum phosphorus levels associate with coronary atherosclerosis in young adults","volume":"20","author":"Foley","year":"2009","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2021.01.016_bib11","doi-asserted-by":"crossref","DOI":"10.1001\/archinte.167.9.879","article-title":"Relations of serum phosphorus and calcium levels to the incidence of cardiovascular disease in the community","volume":"167","author":"Dhingra","year":"2007","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.kint.2021.01.016_bib12","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0167-5273(97)02971-9","article-title":"Serum calcium, phosphorus and albumin levels in relation to the angiographic severity of coronary artery disease","volume":"60","author":"Narang","year":"1997","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.kint.2021.01.016_bib13","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1161\/ATVBAHA.111.231001","article-title":"Dietary phosphate modulates atherogenesis and insulin resistance in apolipoprotein E knockout mice-brief report","volume":"31","author":"Ellam","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.kint.2021.01.016_bib14","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.1161\/CIRCULATIONAHA105.541854","article-title":"Sevelamer prevents uremia-enhanced atherosclerosis progression in apolipoprotein E-deficient mice","volume":"112","author":"Phan","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.kint.2021.01.016_bib15","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1093\/ndt\/gfr254","article-title":"Lanthanum carbonate, like sevelamer-HCL, retards the progression of vascular calcification and atherosclerosis in uremic apolipoprotein E-deficient mice","volume":"27","author":"Nikolov","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2021.01.016_bib16","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.atherosclerosis.2011.09.002","article-title":"Phosphate: the new cholesterol? The role of the phosphate axis in non-uremic vascular disease","volume":"220","author":"Ellam","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.kint.2021.01.016_bib17","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.nutres.2013.05.004","article-title":"Dietary phosphate restriction induces hepatic lipid accumulation through dysregulation of cholesterol metabolism in mice","volume":"33","author":"Tanaka","year":"2013","journal-title":"Nutr Res"},{"key":"10.1016\/j.kint.2021.01.016_bib18","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.cmet.2012.09.002","article-title":"Expanding roles for SREBP in metabolism","volume":"16","author":"Shao","year":"2012","journal-title":"Cell Metab"},{"key":"10.1016\/j.kint.2021.01.016_bib19","doi-asserted-by":"crossref","first-page":"3918","DOI":"10.1074\/jbc.RA119.011849","article-title":"Ring finger protein 5 activates sterol regulatory element-binding protein 2 (SREBP2) to promote cholesterol biosynthesis via ubiquitinating SREBP chaperone SCAP","volume":"295","author":"Kuan","year":"2020","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.kint.2021.01.016_bib20","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1146\/annurev-biochem-062917-011852","article-title":"Retrospective on cholesterol homeostasis: the central role of Scap","volume":"87","author":"Brown","year":"2018","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.kint.2021.01.016_bib21","doi-asserted-by":"crossref","first-page":"8729","DOI":"10.1074\/jbc.M117.783894","article-title":"Cholesterol-induced conformational changes in the sterol-sensing domain of the Scap protein suggest feedback mechanism to control cholesterol synthesis","volume":"292","author":"Gao","year":"2017","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.kint.2021.01.016_bib22","doi-asserted-by":"crossref","first-page":"11235","DOI":"10.1073\/pnas.96.20.11235","article-title":"Sterols regulate cycling of SREBP cleavage-activating protein (SCAP) between endoplasmic reticulum and Golgi","volume":"96","author":"Nohturfft","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.kint.2021.01.016_bib23","doi-asserted-by":"crossref","first-page":"7547","DOI":"10.1074\/jbc.M113.545699","article-title":"Sterol regulatory element-binding protein (SREBP) cleavage regulates Golgi-to-endoplasmic reticulum recycling of SREBP cleavage-activating protein (SCAP)","volume":"289","author":"Shao","year":"2014","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.kint.2021.01.016_bib24","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.ccell.2015.09.021","article-title":"Glucose-mediated N-glycosylation of SCAP is essential for SREBP-1 activation and tumor growth","volume":"28","author":"Cheng","year":"2015","journal-title":"Cancer Cell"},{"key":"10.1016\/j.kint.2021.01.016_bib25","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1161\/ATVBAHA.113.301301","article-title":"Inflammatory stress induces statin resistance by disrupting 3-hydroxy-3-methylglutaryl-CoA reductase feedback regulation","volume":"34","author":"Chen","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.kint.2021.01.016_bib26","doi-asserted-by":"crossref","first-page":"F236","DOI":"10.1152\/ajprenal.00646.2010","article-title":"Advanced glycation end products (AGEs) increase human mesangial foam cell formation by increasing Golgi SCAP glycosylation in\u00a0vitro","volume":"301","author":"Yuan","year":"2011","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.kint.2021.01.016_bib27","doi-asserted-by":"crossref","first-page":"3437","DOI":"10.1096\/fj.201800975RRR","article-title":"SCAP knockdown in vascular smooth muscle cells alleviates atherosclerosis plaque formation via up-regulating autophagy in ApoE-\/- mice","volume":"33","author":"Li","year":"2019","journal-title":"FASEB J"},{"key":"10.1016\/j.kint.2021.01.016_bib28","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1046\/j.1523-1755.2001.00025.x","article-title":"Dysregulation of LDL receptor under the influence of inflammatory cytokines: a new pathway for foam cell formation","volume":"60","author":"Ruan","year":"2001","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2021.01.016_bib29","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1002\/hep.22423","article-title":"Inflammatory stress exacerbates lipid accumulation in hepatic cells and fatty livers of apolipoprotein E knockout mice","volume":"48","author":"Ma","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.kint.2021.01.016_bib30","doi-asserted-by":"crossref","first-page":"E10","DOI":"10.1161\/01.RES.87.7.e10","article-title":"Phosphate regulation of vascular smooth muscle cell calcification","volume":"87","author":"Jono","year":"2000","journal-title":"Circ Res"},{"key":"10.1016\/j.kint.2021.01.016_bib31","doi-asserted-by":"crossref","first-page":"17243","DOI":"10.1074\/jbc.273.27.17243","article-title":"Topology of SREBP cleavage-activating protein, a polytopic membrane protein with a sterol-sensing domain","volume":"273","author":"Nohturfft","year":"1998","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.kint.2021.01.016_bib32","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1093\/glycob\/4.5.551","article-title":"Mammalian alpha-mannosidases\u2014multiple forms but a common purpose?","volume":"4","author":"Daniel","year":"1994","journal-title":"Glycobiology"},{"key":"10.1016\/j.kint.2021.01.016_bib33","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0304-4165(02)00388-4","article-title":"Golgi alpha-mannosidase II deficiency in vertebrate systems: implications for asparagine-linked oligosaccharide processing in mammals","volume":"1573","author":"Moremen","year":"2002","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.kint.2021.01.016_bib34","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/ki.2012.300","article-title":"High phosphate directly affects endothelial function by downregulating annexin II","volume":"83","author":"Di Marco","year":"2013","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2021.01.016_bib35","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/nrneph.2009.184","article-title":"An update on the lipid nephrotoxicity hypothesis","volume":"5","author":"Ruan","year":"2009","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.kint.2021.01.016_bib36","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1134\/S0006297910070011","article-title":"Lipid signaling in the atherogenesis context","volume":"75","author":"Smirnov","year":"2010","journal-title":"Biochemistry (Mosc)"},{"key":"10.1016\/j.kint.2021.01.016_bib37","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.1161\/ATVBAHA.118.311664","article-title":"Myeloid HMG-CoA (3-hydroxy-3-methylglutaryl-coenzyme A) reductase determines atherosclerosis by modulating migration of macrophages","volume":"38","author":"Sakai","year":"2018","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.kint.2021.01.016_bib38","doi-asserted-by":"crossref","first-page":"13479","DOI":"10.1074\/jbc.M116.728469","article-title":"Contribution of accelerated degradation to feedback regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase and cholesterol metabolism in the liver","volume":"291","author":"Hwang","year":"2016","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.kint.2021.01.016_bib39","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.1016\/j.jmb.2016.02.030","article-title":"Glycosylation quality control by the Golgi structure","volume":"428","author":"Zhang","year":"2016","journal-title":"J\u00a0Mol Biol"},{"key":"10.1016\/j.kint.2021.01.016_bib40","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1146\/annurev.bi.54.070185.003215","article-title":"Assembly of asparagine-linked oligosaccharides","volume":"54","author":"Kornfeld","year":"1985","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.kint.2021.01.016_bib41","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/nrm3383","article-title":"Vertebrate protein glycosylation: diversity, synthesis and function","volume":"13","author":"Moremen","year":"2012","journal-title":"Nat Rev Mol Cell Biol"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253821001885?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253821001885?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T00:59:16Z","timestamp":1758761956000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253821001885"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":41,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S0085253821001885"],"URL":"https:\/\/doi.org\/10.1016\/j.kint.2021.01.016","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hyperphosphatemia in chronic kidney disease exacerbates atherosclerosis via a mannosidases-mediated complex-type conversion of SCAP N-glycans","name":"articletitle","label":"Article Title"},{"value":"Kidney International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.kint.2021.01.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier, Inc., on behalf of the International Society of Nephrology.","name":"copyright","label":"Copyright"}]}}